Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?

International Journal of Impotence Research volume 20, pages 501–506 (2008)Cite this article

Abstract

Veterans (N=41) with type II diabetes were enrolled in a behavioral and pharmacologic intervention for cardiac risk reduction for 4 weeks at the Providence Veterans Affairs Medical Center during 2004–2007 and were followed up 3 months post intervention. Erectile dysfunction (ED) was assessed using the 5-item version of the International Index of Erectile Function (IIEF-5). Participants experienced significant improvements in hemoglobin A1c (HbA1c), diastolic blood pressure and total cholesterol levels over the course of the intervention. Change in systolic and diastolic blood pressure and reduction in or maintenance of HbA1c below 7.0% were significantly associated with change in IIEF-5 (P=0.01, P=0.01, P=0.04, respectively). These results suggest that improved blood pressure and glycemic control in men with diabetes may lead to an improvement in ED.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Romeo JH, Seftel AD, Madhun ZT, Aron DC . Sexual function in men with diabetes type 2: association with glycemic control. J Urol 2000; 163: 788–791.

    Article  CAS  PubMed  Google Scholar 

  2. Feldman HA, Goldstein I, Gatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151: 54–61.

    Article  CAS  PubMed  Google Scholar 

  3. Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S . Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005; 48: 512–518.

    Article  PubMed  Google Scholar 

  4. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB . Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847.

    Article  CAS  PubMed  Google Scholar 

  5. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421–431.

    Article  CAS  PubMed  Google Scholar 

  6. Wei M, Macera CA, Davis DR, Hornung CA, Nankin HR, Blair SN . Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994; 140: 930–937.

    Article  CAS  PubMed  Google Scholar 

  7. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

    Article  CAS  PubMed  Google Scholar 

  8. Miyata Y, Shindo K, Matsuya F, Noguchi M, Nishikido M, Koga S et al. Erectile dysfunction in hemodialysis patients with diabetes mellitus: association with age and hemoglobin A1c levels. Int J Urol 2004; 11: 530–534.

    Article  PubMed  Google Scholar 

  9. Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ et al. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 2007; 4: 1269–1276.

    Article  PubMed  Google Scholar 

  10. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004; 291: 2978–2984.

    Article  CAS  PubMed  Google Scholar 

  11. Saltzman EA, Guay AT, Jacobson J . Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004; 172: 255–258.

    Article  PubMed  Google Scholar 

  12. Guay AT, Perez JB, Heatley GJ . Cessation of smoking rapidly decreases erectile dysfunction. Endocr Pract 1998; 4: 23–26.

    Article  CAS  PubMed  Google Scholar 

  13. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB . Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.

    Article  CAS  PubMed  Google Scholar 

  14. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  PubMed  Google Scholar 

  15. American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care 2008; 31: S12–S54.

    Article  Google Scholar 

  16. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M . Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001; 108: 1341–1348.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Siu SC, Lo SK, Wong KW, Ip KM, Wong YS . Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet Med 2001; 18: 732–738.

    Article  CAS  PubMed  Google Scholar 

  18. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

    Article  CAS  PubMed  Google Scholar 

  19. Wein AJ, Van Arsdalen K . Drug induced male sexual dysfunction. Urol Clin North Am 1988; 15: 23.

    CAS  PubMed  Google Scholar 

  20. Francis ME, Kusek JW, Nyberg LM, Eggers PW . The contribution of common medical conditions and drug exposures to erectile dysfunction in adult males. J Urol 2007; 178: 591–596.

    Article  PubMed  Google Scholar 

  21. Hale TM, Okabe H, Bushfield TL, Heaton JP, Adams MA . Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol 2002; 168: 348–354.

    Article  CAS  PubMed  Google Scholar 

  22. Thomas DR . Medications and sexual function. Clin Geriatr Med 2003; 19: 553–562.

    Article  PubMed  Google Scholar 

  23. Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ et al. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int J Clin Pract 2006; 60: 141–145.

    Article  CAS  PubMed  Google Scholar 

  24. Pinnock CB, Stapleton AM, Marshall VR . Erectile dysfunction in the community: a prevalence study. Med J Aust 1999; 171: 353–357.

    Article  CAS  PubMed  Google Scholar 

  25. Roumeguère T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC . Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003; 44: 355–359.

    Article  PubMed  Google Scholar 

  26. Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 1998; 97: 1453–1460.

    Article  CAS  PubMed  Google Scholar 

  27. Rosen RC, Cappelleri JC, Gendrano III N . The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226–244.

    Article  CAS  PubMed  Google Scholar 

  28. Fedele D, Coscelli C, Cucinotta D, Forti G, Santeusanio F, Viaggi S et al. Incidence of erectile dysfunction in Italian men with diabetes. J Urol 2001; 166: 1368–1371.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Target Research Enhancement Program, Providence Veterans Affairs Medical Center, Providence, RI, USA

    S A M Khatana, T H Taveira & W-C Wu

  2. College of Pharmacy, University of Rhode Island, Kingston, RI, USA

    T H Taveira

  3. Department of Family Medicine, Men's Health Center, Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA

    M M Miner

  4. Department of Family Medicine, Memorial Hospital of Rhode Island, Warren Alpert Medical School of Brown University, Providence, RI, USA

    C B Eaton

  5. Department of Medicine, Providence Veterans Affairs Medical Center, Warren Alpert Medical School of Brown University, Providence, RI, USA

    W-C Wu

Authors
  1. S A M Khatana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T H Taveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M M Miner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C B Eaton
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W-C Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W-C Wu.

Additional information

Financial disclosure

The authors state no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khatana, S., Taveira, T., Miner, M. et al. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type II diabetes mellitus?. Int J Impot Res 20, 501–506 (2008). https://doi.org/10.1038/ijir.2008.36

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2008.36

Keywords

This article is cited by

Search

Advanced search

Quick links